Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Growth and differentiation factor 15 as a biomarker for mitochondrial myopathy.

Poulsen NS, Madsen KL, Hornsyld TM, Eisum AV, Fornander F, Buch AE, Stemmerik MG, Ruiz-Ruiz C, Krag TO, Vissing J.

Mitochondrion. 2019 Oct 26;50:35-41. doi: 10.1016/j.mito.2019.10.005. [Epub ahead of print]

PMID:
31669236
2.

No effect of triheptanoin on exercise performance in McArdle disease.

Madsen KL, Laforêt P, Buch AE, Stemmerik MG, Ottolenghi C, Hatem SN, Raaschou-Pedersen DT, Poulsen NS, Atencio M, Luton MP, Ceccaldi A, Haller RG, Quinlivan R, Mochel F, Vissing J.

Ann Clin Transl Neurol. 2019 Oct;6(10):1949-1960. doi: 10.1002/acn3.50863. Epub 2019 Sep 14.

3.

Impaired Fat Oxidation During Exercise in Long-Chain Acyl-CoA Dehydrogenase Deficiency Patients and Effect of IV-Glucose.

Madsen KL, Stemmerik MG, Buch AE, Poulsen NS, Lund AM, Vissing J.

J Clin Endocrinol Metab. 2019 Sep 1;104(9):3610-3613. doi: 10.1210/jc.2019-00453.

PMID:
30990523
4.

Muscle contractility in spinobulbar muscular atrophy.

Dahlqvist JR, Oestergaard ST, Poulsen NS, Knak KL, Thomsen C, Vissing J.

Sci Rep. 2019 Mar 18;9(1):4680. doi: 10.1038/s41598-019-41240-y.

5.

Refining the spinobulbar muscular atrophy phenotype by quantitative MRI and clinical assessments.

Dahlqvist JR, Oestergaard ST, Poulsen NS, Thomsen C, Vissing J.

Neurology. 2019 Feb 5;92(6):e548-e559. doi: 10.1212/WNL.0000000000006887. Epub 2019 Jan 4.

PMID:
30610091
6.

Disease progression and outcome measures in spinobulbar muscular atrophy.

Dahlqvist JR, Fornander F, de Stricker Borch J, Oestergaard ST, Poulsen NS, Vissing J.

Ann Neurol. 2018 Nov;84(5):754-765. doi: 10.1002/ana.25345. Epub 2018 Oct 25.

PMID:
30255951
7.

Muscle contractility of leg muscles in patients with mitochondrial myopathies.

Poulsen NS, Dahlqvist JR, Hedermann G, Løkken N, Vissing J.

Mitochondrion. 2019 May;46:221-227. doi: 10.1016/j.mito.2018.07.001. Epub 2018 Jul 11.

PMID:
30017555
8.

Phenotype and genotype of muscle ryanodine receptor rhabdomyolysis-myalgia syndrome.

Witting N, Laforêt P, Voermans NC, Roux-Buisson N, Bompaire F, Rendu J, Duno M, Feillet F, Kamsteeg EJ, Poulsen NS, Dahlqvist JR, Romero NB, Fauré J, Vissing J, Behin A.

Acta Neurol Scand. 2018 May;137(5):452-461. doi: 10.1111/ane.12885. Epub 2017 Dec 29.

PMID:
29635721

Supplemental Content

Loading ...
Support Center